Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Ampio Pharmaceuticals, Inc. logo — company profile

Ampio Pharmaceuticals, Inc.

Founded 2011 United States Englewood, United States 7 employees Post Ipo Equity Total: $75.89M Biotechnology, Health Care

General Information

Company Name Ampio Pharmaceuticals, Inc.
Founded Year 2011
Location United States Englewood, United States +1
Employees 7
Industries Biotechnology, Health Care
Funding Stage Post Ipo Equity
Social

Get notified when Ampio Pharmaceuticals, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals, Inc. is a development stage biopharmaceutical company founded in 2011 in the United States. The company is dedicated to the discovery and development of novel therapies that target common inflammatory conditions with limited treatment options. Their focus lies in developing compounds that address significant medical needs in areas such as osteoarthritis and diabetic macular edema, as well as other prevalent inflammatory diseases. They achieve this through an innovative discovery and development platform. Ampio Pharmaceuticals recently secured a $12.00M investment in Post-IPO Equity on 19 June 2019. This investment aims to support the company's efforts in advancing their pipeline and bringing novel therapies to the market. While the details about the specific investors involved in this last investment round are not available, the funds are expected to drive the company's research and development initiatives, potentially leading to significant advancements in the treatment of inflammatory conditions.

Taxonomy: biopharmaceutical, development stage, novel therapies, inflammatory conditions, osteoarthritis, diabetic macular edema, discovery, development platform, medical needs, treatment options, pharmaceutical research, drug development, clinical trials

Funding Rounds & Investors (3)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Equity •••••• - 19 Jun 2019
Post-IPO Equity •••••• - 05 Mar 2014
Seed Round •••••• - 25 Mar 2011

Ampio Pharmaceuticals, Inc. Alternatives & Competitors

Ampio Pharmaceuticals, Inc. vs
Flame Biosciences
Flame Biosciences

A clinical-stage pioneer focused on discovering, developing, and commercializing groundbreaking ther...

Series Unknown
1 employees
Biotechnology, Health Care
Ampio Pharmaceuticals, Inc. vs
Rhizen Pharmaceuticals AG
Rhizen Pharmaceuticals AG Switzerland

Developing The Next Generation Medicines That Will Lead The Fight Against Cancer

5 employees
Biotechnology, Pharmaceutical
Ampio Pharmaceuticals, Inc. vs
Locus Pharmaceuticals
Locus Pharmaceuticals

Locus Pharmaceuticals, Inc. is a privately held drug discovery and development biotechnology company...

Debt Financing
6 employees
Biotechnology, Pharmaceutical

FAQ About Ampio Pharmaceuticals, Inc.

Ampio Pharmaceuticals is a development stage biopharmaceutical company focused on the discovery and development of novel therapies aimed at treating common inflammatory conditions for which there are limited treatment options. We are developing compounds that serve significant medical needs in osteo...
Ampio Pharmaceuticals, Inc. was founded in 2011.
Ampio Pharmaceuticals, Inc. is headquartered in Englewood, United States.
Ampio Pharmaceuticals, Inc. operates in the following industries: Biotechnology, Health Care.
Ampio Pharmaceuticals, Inc. has approximately 7 employees.
Ampio Pharmaceuticals, Inc. has completed 3 funding rounds, raising a total of $75.89M. The latest funding stage is Post Ipo Equity.
Top alternatives and competitors to Ampio Pharmaceuticals, Inc. include Flame Biosciences, Rhizen Pharmaceuticals AG, Locus Pharmaceuticals, LYNK Pharmaceuticals, Amira Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Ampio Pharmaceuticals, Inc. and Flame Biosciences are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Ampio Pharmaceuticals, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy